Table 3.
Characteristics | Enhanced | Commercial | |
Alerts for patients who had a visit with primary care during the evaluation period, na | |||
Total number of alerts | 106 | 59 | |
Unique visits or encounters | 104 | 59 | |
Unique patients with alert | 61 | 26 | |
Unique clinicians alerted | 87 | 31 | |
Adoption (did not outright dismiss clinical decision support alert), n (%) | |||
Alerts adopted | 66 (62.3) | 17 (28) | |
Unique patients | 44 (72) | 13 (1) | |
Unique clinicians exposed to the alert | 60 (69) | 13 (41) | |
Clinicians who adopted with the first alert | 55 (63) | 11 (35) | |
Effectiveness, n (%) | |||
Alerts where BBb was prescribed | 15 (14.2) | 0 (0) | |
Unique patients where BB was prescribed | 15 (25) | 0 (0) | |
Unique patients prescribed with first alert | 13 (87) | 0 (0) | |
Unique patients prescribed BB by assigned primary care provider | 7 (47) | 0 (0) | |
Unique clinicians who ever prescribed BB | 14 (16) | 0 (0) | |
Clinicians who were attending physicians | 9 (60) | 0 (0) | |
Clinicians who were advanced practice clinicians | 3 (21) | 0 (0) | |
Clinicians who were a medical resident or fellow | 2 (14) | 0 (0) |
aFour patients were exposed to both alerts, and 1 clinician was exposed to both alerts. One clinician prescribed a BB to 2 different patients.
bBB: beta-blocker.